PEPE, Stefano
PEPE, Stefano
Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy
2022-01-01 Conti, V.; Stefanelli, B.; Bellis, E. D.; Sellitto, C.; Bertini, N.; Manzo, V.; Pascale, D. D.; Sabbatino, F.; Pepe, S.; Corbi, G.; Filippelli, A.
5-Aza-2'-Deoxycitidine induces growth-inhibition and up-regulation of epidermal-growth factor receptor on human epithelial cancer-cells
1994-01-01 M., Caraglia; A., Pinto; P., Correale; V., Zagonel; G., Genua; A., Leardi; Pepe, Stefano; A. R., Bianco; P., Tagliaferri
8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells
1996-01-01 G., DI ISERNIA; F., Ciardiello; C., Sandomenico; Pepe, Stefano; A. R., Bianco; G., Tortora
8-Cl-cAMP in differentiation therapy: The reversal and suppression of malignancy targeting the intracellular transducing proteins of cAMP.
1991-01-01 Y. S., Cho Cgung; H., Yokozaki; G., Tortora; Pepe, Stefano; T., Clair
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature
2020-01-01 Conti, V.; De Bellis, E.; Manzo, V.; Sabbatino, F.; Iannello, F.; Piaz, F. D.; Izzo, V.; Charlier, B.; Stefanelli, B.; Torsiello, M.; Iannaccone, T.; Coglianese, A.; Colucci, F.; Pepe, S.; Filippelli, A.
A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
2005-01-01 F., Caponigro; G., Franchin; V., Rav; G., Silvestro; B., Morrica; C., Romano; E., Minatel; Pepe, Stefano
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck.
2008-01-01 F., Caponigro; C., Romano; A., Milano; R., Solla; G., Franchin; V., Adamo; E., Mari; B., Morrica; Pepe, Stefano
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FLFOX-4) as first-line treatment of advanced gastric cancer patients.
2004-01-01 F., De Vita; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., De Placido; G., Galizia; F., Ciardiello; G., Catalano; A. R., Bianco
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
2005-01-01 F., DE VITA; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., DE PLACIDO; G., Galizia; N., DI MARTINO; F., Ciardiello; G., Catalano; A. R., Bianco
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
2011-01-01 Della Vittoria Scarpati, G.; Carlomagno, C.; Marchini, S.; Ubezio, P.; Falcetta, F.; D'Incalci, M.; De Placido, S.; Sabbatino, F.; Fusciello, C.; Pepe, S.
A Specific miRNA Signature Correlates with Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
2011-01-01 DELLA VITTORIA SCARPATI, G.; Falcetta, F.; Carlomagno, C.; Ubezio, P.; Marchini, S.; DE STEFANO, A.; Singh, V. K.; D'Incalci, M.; DE PLACIDO, S.; Pepe, Stefano
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC
2020-01-01 Sabbatino, Francesco; Polcaro, Giovanna; Liguori, Luigi; Manzo, Valentina; Conti, Valeria; Col, Jessica Dal; Vergatti, Anita; Stellato, Cristiana; Casolaro, Vincenzo; Filippelli, Amelia; Ferrone, Soldano; Pepe, Stefano
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
2014-01-01 Sabbatino, Francesco; Wang, Yangyang; Wang, Xinhui; Flaherty, Keith T.; Pepin, David; Scognamiglio, Giosuè; Yu, Ling; Cooper, Zachary A.; Pepe, Stefano; Kirkwood, John M.; Frederick, Dennie T.; Wargo, Jennifer A.; Ferrone, Soldano; Ferrone, Cristina R.
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma
2016-01-01 Sabbatino, Francesco; Wang, Yangyang; Scognamiglio, Giosuè; Favoino, Elvira; Feldman, Steven A.; Villani, Vincenzo; Flaherty, Keith T.; Nota, Sjoerd; Giannarelli, Diana; Simeone, Ester; Anniciello, Anna M.; Palmieri, Giuseppe; Pepe, Stefano; Botti, Gerardo; Ascierto, Paolo A.; Ferrone, Cristina R.; Ferrone, Soldano
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.
2007-01-01 G., DI LORENZO; A., Rea; C., Carlomagno; Pepe, Stefano; G., Palmieri; R., Labianca; A., Chirianni; A., DE STEFANO; V., Esposito; S., DE PLACIDO; V., Montesarchio
ADDITION OF ERLOTINIB TO FLUROPYRIMIDINE-OXALIPLATIN-BASED CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB: TWO SEQUENTIAL PHASE I TRIALS.
2011-01-01 C., Carlomagno; G., Daniele; R., Baianco; R., Marciano; V., Damiano; E., Matano; L., Nappi; Pepe, Stefano; S., DE PLACIDO; G., Tortora
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-a genes on in vitro transformation of human mammary epithelial cells.
1992-01-01 F., Ciardiello; M., Gottardis; F., Basolo; Pepe, Stefano; N., Normanno; R. B., Dickson; A. R., Bianco; D. S., Salomon
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom?
2014-01-01 A., De Stefano; R., Moretto; L., Bucci; Pepe, Stefano; F. J., Romano; A. C., Cella; L., Attademo; M., Rosanova; S., De Falco; G., Fiore; L., Raimondo; S., De Placido; C., Carlomagno
Adjuvant treatment of diabetic foot
2013-01-01 Lo Pardo, D; Pezzuti, G; Selleri, Carmine; Pepe, Stefano; Esposito, Silvano
Altre Neoplasie
2007-01-01 Pepe, Stefano; A., Contegiacomo; E., Matano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy | 1-gen-2022 | Conti, V.; Stefanelli, B.; Bellis, E. D.; Sellitto, C.; Bertini, N.; Manzo, V.; Pascale, D. D.; Sabbatino, F.; Pepe, S.; Corbi, G.; Filippelli, A. | |
| 5-Aza-2'-Deoxycitidine induces growth-inhibition and up-regulation of epidermal-growth factor receptor on human epithelial cancer-cells | 1-gen-1994 | M., Caraglia; A., Pinto; P., Correale; V., Zagonel; G., Genua; A., Leardi; Pepe, Stefano; A. R., Bianco; P., Tagliaferri | |
| 8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells | 1-gen-1996 | G., DI ISERNIA; F., Ciardiello; C., Sandomenico; Pepe, Stefano; A. R., Bianco; G., Tortora | |
| 8-Cl-cAMP in differentiation therapy: The reversal and suppression of malignancy targeting the intracellular transducing proteins of cAMP. | 1-gen-1991 | Y. S., Cho Cgung; H., Yokozaki; G., Tortora; Pepe, Stefano; T., Clair | |
| A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature | 1-gen-2020 | Conti, V.; De Bellis, E.; Manzo, V.; Sabbatino, F.; Iannello, F.; Piaz, F. D.; Izzo, V.; Charlier, B.; Stefanelli, B.; Torsiello, M.; Iannaccone, T.; Coglianese, A.; Colucci, F.; Pepe, S.; Filippelli, A. | |
| A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN) | 1-gen-2005 | F., Caponigro; G., Franchin; V., Rav; G., Silvestro; B., Morrica; C., Romano; E., Minatel; Pepe, Stefano | |
| A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. | 1-gen-2008 | F., Caponigro; C., Romano; A., Milano; R., Solla; G., Franchin; V., Adamo; E., Mari; B., Morrica; Pepe, Stefano | |
| A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FLFOX-4) as first-line treatment of advanced gastric cancer patients. | 1-gen-2004 | F., De Vita; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., De Placido; G., Galizia; F., Ciardiello; G., Catalano; A. R., Bianco | |
| A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. | 1-gen-2005 | F., DE VITA; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., DE PLACIDO; G., Galizia; N., DI MARTINO; F., Ciardiello; G., Catalano; A. R., Bianco | |
| A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer | 1-gen-2011 | Della Vittoria Scarpati, G.; Carlomagno, C.; Marchini, S.; Ubezio, P.; Falcetta, F.; D'Incalci, M.; De Placido, S.; Sabbatino, F.; Fusciello, C.; Pepe, S. | |
| A Specific miRNA Signature Correlates with Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. | 1-gen-2011 | DELLA VITTORIA SCARPATI, G.; Falcetta, F.; Carlomagno, C.; Ubezio, P.; Marchini, S.; DE STEFANO, A.; Singh, V. K.; D'Incalci, M.; DE PLACIDO, S.; Pepe, Stefano | |
| Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC | 1-gen-2020 | Sabbatino, Francesco; Polcaro, Giovanna; Liguori, Luigi; Manzo, Valentina; Conti, Valeria; Col, Jessica Dal; Vergatti, Anita; Stellato, Cristiana; Casolaro, Vincenzo; Filippelli, Amelia; Ferrone, Soldano; Pepe, Stefano | |
| Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation | 1-gen-2014 | Sabbatino, Francesco; Wang, Yangyang; Wang, Xinhui; Flaherty, Keith T.; Pepin, David; Scognamiglio, Giosuè; Yu, Ling; Cooper, Zachary A.; Pepe, Stefano; Kirkwood, John M.; Frederick, Dennie T.; Wargo, Jennifer A.; Ferrone, Soldano; Ferrone, Cristina R. | |
| Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma | 1-gen-2016 | Sabbatino, Francesco; Wang, Yangyang; Scognamiglio, Giosuè; Favoino, Elvira; Feldman, Steven A.; Villani, Vincenzo; Flaherty, Keith T.; Nota, Sjoerd; Giannarelli, Diana; Simeone, Ester; Anniciello, Anna M.; Palmieri, Giuseppe; Pepe, Stefano; Botti, Gerardo; Ascierto, Paolo A.; Ferrone, Cristina R.; Ferrone, Soldano | |
| Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study. | 1-gen-2007 | G., DI LORENZO; A., Rea; C., Carlomagno; Pepe, Stefano; G., Palmieri; R., Labianca; A., Chirianni; A., DE STEFANO; V., Esposito; S., DE PLACIDO; V., Montesarchio | |
| ADDITION OF ERLOTINIB TO FLUROPYRIMIDINE-OXALIPLATIN-BASED CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB: TWO SEQUENTIAL PHASE I TRIALS. | 1-gen-2011 | C., Carlomagno; G., Daniele; R., Baianco; R., Marciano; V., Damiano; E., Matano; L., Nappi; Pepe, Stefano; S., DE PLACIDO; G., Tortora | |
| Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-a genes on in vitro transformation of human mammary epithelial cells. | 1-gen-1992 | F., Ciardiello; M., Gottardis; F., Basolo; Pepe, Stefano; N., Normanno; R. B., Dickson; A. R., Bianco; D. S., Salomon | |
| Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom? | 1-gen-2014 | A., De Stefano; R., Moretto; L., Bucci; Pepe, Stefano; F. J., Romano; A. C., Cella; L., Attademo; M., Rosanova; S., De Falco; G., Fiore; L., Raimondo; S., De Placido; C., Carlomagno | |
| Adjuvant treatment of diabetic foot | 1-gen-2013 | Lo Pardo, D; Pezzuti, G; Selleri, Carmine; Pepe, Stefano; Esposito, Silvano | |
| Altre Neoplasie | 1-gen-2007 | Pepe, Stefano; A., Contegiacomo; E., Matano |